SMS Pharmaceuticals Ltd. Financials: Quarterly Results
Revenue
243.86
Cr.
PAT
25.13
Cr.
EBITDA
39.78
Cr.
SMS Pharmaceuticals Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 242.43 | 196.05 | 248.20 | 173.35 | 196.75 |
| Total Income From Operations (Cr.) | 242.43 | 196.05 | 248.20 | 173.35 | 196.75 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 39.78 | 30.21 | 33.59 | 26.64 | 24.15 |
| P/L Before Exceptional Items & Tax (Cr.) | 34.04 | 24.37 | 28.52 | 22.44 | 19.54 |
| P/L After Tax from Ordinary Activities (Cr.) | 25.13 | 18.71 | 20.08 | 17.08 | 13.86 |
| Net Profit/Loss For the Period (Cr.) | 25.13 | 18.71 | 20.08 | 17.08 | 13.86 |
| Basic EPS | 2.84 | 2.31 | 2.40 | 2.15 | 1.67 |
FAQs
SMS Pharmaceuticals Ltd. announced its quarterly results for Q2 FY2026 on November 10, 2025.
In Q2 FY2026, SMS Pharmaceuticals Ltd. are as follows:
Revenue: ₹243.86 crore
Net Profit: ₹25.13 crore.
For Q2 FY2026, SMS Pharmaceuticals Ltd. posted ₹243.86 crore in revenue and ₹25.13 crore in net profit.
Past quarterly results for SMS Pharmaceuticals Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.